Complexa
ClosedBerwyn · Founded 2012
- Headquarters
- Berwyn
- Employees
- 11–50
- Founded
- 2012
- Business Model
- B2B
- Website
- complexarx.com
- Last Round
- Series CJul 2017
- Rounds
- 4
About
Complexa Inc. is a clinical-stage biopharmaceutical company based in Berwyn, Pennsylvania, developing nitrated fatty acids (NFAs) for the treatment of debilitating fibrotic and inflammatory orphan diseases. Its lead compound CXA-10 is in Phase 2 development for focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH). Investors include NEA, Pfizer Venture Investments, Andera Partners, HBM Healthcare Investments, and JAFCO.
Summary
Complexa is a Biopharmaceutical company based in Berwyn, founded in 2012. Its most recent funding was a Series C round in Jul 2017. Investors include New Enterprise Associates, Pfizer Ventures and JAFCO Life Science Investment.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2017
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
R&D company with 1 SBIR/STTR awards from Department of Health and Human Services.
Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...
Biopharmaceutical company developing RAS/MAPK pathway therapies for cancer patients.
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...
A clinical-stage biopharma company based in Lyon, France
Clinical-stage biopharmaceutical company focused on the development of oral small molecule therap...